FDA Approves New Stroke Treatment: Faster Clot-Busting Drug TNKase
07 Mar 2025
The U.S. Food and Drug Administration (FDA) has approved tenecteplase (TNKase) as a groundbreaking treatment for acute ischemic stroke (AIS), marking the first new clot-busting drug in nearly 30 years. Stroke remains a leading cause of death and disability, affecting over 795,000 people annually in the United States alone. This...
Read More
